|
|
Article: Geron's Telomerase Promoter to be Highlighted At the Annual Meeting of the American Society of Gene Therapy.
- Article from:
- Business Wire
- Article date:
- May 30, 2002
CopyrightCOPYRIGHT 2002 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Medical Writers
American Society of Gene Therapy
MENLO PARK, Calif.--(BW HealthWire)--May 30, 2002
14 Abstracts Highlight the Universality of Telomerase
Promoter-Based Therapies and Telomerase for Treatment of Cancer
Geron Corporation (Nasdaq:GERN) announced today that 14 studies showcasing the effectiveness and universality of the telomerase promoter technology, telomerase and associated gene therapies will be presented next week at the 5th annual meeting of the American Society of Gene Therapy (ASGT) at the John B. Hynes Memorial Convention Center in Boston, Mass., June 5-9.
Human telomerase is ...